We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug & Device Products
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Publications
    • Webinar Training Pass
    • eCFR and Guidances
    • Books
  • Clinical Products
  • Advertising
  • White Papers
  • Contact Us
  • About Us
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Webinars

Now get all the training you need – all in one place, and all for one low price!

The FDAnews Webinar Training Pass program gives you year-round unrestricted access to any of the hundreds of webinars listed below. These training programs feature top consultants, expert speakers and FDA officials.

PLUS, subscribers get automatic access to all our new training programs for the next 12 months – that’s more than 50 new programs a year!

If you are already a Training Pass member login below and then scroll down to view the list in date order or narrow your search by keyword or category. Viewing the webinar is easy… simply identify the webinar you want to watch, click on the title and the video will begin. If you would like to view or download the presentation materials separately from the video click the "Download Presentation" link.

LOGIN

BUY NOW Single-User 1-Year Unlimited Access $1,297

Also available: Take advantage of our multi-user and site licenses of the Webinar Training Pass, so you’ll have the most-informed workforce! Contact Will Tuttle, Business Development Representative at wtuttle@fdanews.com or +1 612.216.2948 to receive a custom quote.

Search by keyword, speaker name or just by category (drug, device or clinical) and you'll find all you need.

If you have any questions or are having any problems please give us a call on 703.538.7600 or email customer service.

Webinar Training Pass

Reducing Complexity in Starting Clinical Trials: More Patients, Faster Startup
62 minutes

Recorded on: Jan. 26, 2021

Description: A panel of experts discusses using technology to increase study startup speed. They cover:

  • Standardizing processes across multiple sponsors;
  • Market dynamics and industry solutions; and
  • Leveraging data for full study optimization.

Presentation: Download the presentation

Transcript: Download the transcript

Speakers: Sujay Jadhav, Global Vice President, Oracle Health; Larissa Comis, Product Lead, Cognizant Healthcare and Life Sciences; David Morin, Director of Research, Holston Medical Group; Jimmy Bechtel, Vice President, Society of Clinical Research Sites; Patricia Lorusso, Professor of Medical Oncology, Yale School of Medicine

Virtual MDSAP Audits in the Era of COVID-19: What to Know and Do to Pass Virtual Audits
46 minutes

Recorded on: Jan. 21, 2021

Description: Regulatory expert Christy Coleman shares how virtual MDSAP audits are being conducted and what you must do to ensure effective ones. She discusses:

  • Real-world examples of remote MDSAP audit experience;
  • Best practices for managing remote MDSAP audits;
  • Virtual MDSAP audit challenges and how to mitigate them, including issues with video conferencing and file-sharing technologies; and
  • Alternatives when technology does not work as expected.

Presentation: Download the presentation

Transcript: Download the transcript

Speaker: Christy Coleman, Vice President of Regulatory, Irrimax

Pharmaceutical Quality Risk Management: Navigating the Intersection Between Regulatory Requirements and Risk Management
75 minutes

Recorded on: Jan. 19, 2021

Description: Risk management expert Amanda McFarland discusses applying risk-based decisionmaking to ensure the long-term impacts of your company’s current decisions are fully understood. She covers:

  • Ways to integrate quality risk management (QRM) into your quality systems, such as change control and investigations, and how integration can benefit your organization;
  • Risk management tools available to you to meet regulatory requirements, such as process hazard analysis (PHA), risk evaluation and mitigation (REM), hazard analysis critical control point (HACCP), and FMEA; and
  • Recognizing the critical QRM regulations that apply to pharma, such as ICH 9, ICH Q10, ISO 14644 and Annex 1.

Presentation: Download the presentation

Transcript: Download the transcript

Speaker: Amanda McFarland, QRM and Microbiology Senior Consultant, ValSource

Spreadsheet Validation: Best Practices to Maintain Compliance
90 minutes

Recorded on: Jan. 14, 2021

Description: Computer system validation expert David Harrison shares best practices and available options for validating spreadsheets. He discusses:

  • FDA examples of noncompliance and regulatory concerns with respect to 21 CFR 210-211, 21 CFR Part 11 and 21 CFR Part 820;
  • How to determine spreadsheet validation gaps the FDA targets;
  • How to choose an approach for efficient and repeatable validation that fits into your traditional QA and validation processes; and
  • How to plan, manage and resource an effective project.

Presentation: Download the presentation

Transcript: Download the transcript

Speaker: David Harrison, Principal Consultant, CSV Compliance

Develop World-Class SOPs that Minimize Human Error
90 minutes

Recorded on: Jan. 13, 2021

Description: Industrial-organizational psychologist Ginette Collazo explains how to write SOPs that minimize human error. She discusses:

  • How to prepare an outline and develop world-class SOPs;
  • The interrelationship between SOPs, quality and regulatory compliance;
  • How to create and maintain a procedure that minimizes human error; and
  • Use of electronic information networks for procedural access.

Presentation: Download the presentation

Transcript: Download the transcript

Speaker: Ginette Collazo, CEO, Human Error Solutions

Adverse Event Reporting: A Tale of Two Systems
90 minutes

Recorded on: Dec. 17, 2020

Description: Quality systems expert Dan O’Leary presents methods for reporting adverse events in both the U.S. and the EU. He discusses:

  • Key requirements in adverse event reporting to regulators in the U.S. and the EU;
  • Important differences between reporting systems in both regions;
  • Recent changes in the adverse event reporting forms in the U.S. and the EU; and
  • Comparisons of the content expectations in the forms for both systems.

Presentation: Download the presentation

Transcript: Download the transcript

Speaker: Dan O'Leary, President, Ombu Enterprise

Increasing Speed and Accuracy of Remote Audits With Modern Cloud QMS
61 minutes

Recorded on: Dec. 17, 2020

Description: A panel of experts discusses how modern cloud solutions enable organizations to increase the speed and accuracy of virtual audits. Topics include:

  • How the pandemic and remote working have impacted the life sciences industry;
  • The best practices of conducting remote audits;
  • Real-world examples of using cloud QMS to improve audit responsiveness in virtual environments; and
  • How a unified quality environment drives audit and inspection readiness.

Presentation: Download the presentation

Transcript: Download the transcript

Speakers: Snehal Srikrishna, Senior Director of Strategy and Mike Kawano, Director, Vault Quality, Veeva Systems; Ralph Mazenko, Executive Director Clinical QA, Merck; Marcus Massingham, Senior Director, Quality Systems, GlaxoSmithKline

Managing Your Pharmaceutical Suppliers During COVID-19: Pandemic-Era Best Practices
78 minutes

Recorded on: Dec. 16, 2020

Description: Regulatory compliance expert Steven Lynn shares the basics of the COVID-affected supplier relationship, emphasizing the best practices you must incorporate to manage it over time. He discusses:

  • How to structure a pharmaceutical supplier agreement that incorporates specific clauses to assist you in monitoring your supplier during the pandemic;
  • How to use new technology to develop best practices for monitoring and overseeing your supplier partnerships; and
  • How to conduct world-class supplier audits during the pandemic.

Presentation: Download the presentation

Transcript: Download the transcript

Speaker: Steven Lynn, Executive Vice President of Pharmaceuticals, Regulatory Compliance Associates

Drug, Biologics and Combination Products Labeling: Complying with FDA's Most Recent Guidance
58 minutes

Recorded on: Dec. 8, 2020

Description: Food and drug attorney Alan Minsk discusses the FDA’s new labeling guidance on instructions for use (IFU). He covers:

  • The kind of language IFUs should be written in to be patient friendly;
  • What the guidance recommends in terms of voice, commands and sentences;
  • Examples of sample labeling that covers all elements of an IFU from dosage and usage to storage and disposal; and
  • Recommendations the FDA makes in terms of design and layout, such as the use of easy-to-read fonts, sequential numbering and white space.

Presentation: Download the presentation

Transcript: Download the transcript

Speaker: Alan Minsk, Partner, Arnall Golden Gregory

How Will FDA’s New Approach to CSV Make Implementation Easier?
58 minutes

Recorded on: Dec. 3, 2020

Description: Validation expert Tim Fischer discusses the FDA’s new Computer System Assurance (CSA) and its focus on quality risk management. He covers:

  • Critical risk thinking;
  • Computer systems to which CSA applies;
  • Performance metrics needed; and
  • Transition and next steps.

Presentation: Download the presentation

Transcript: Download the transcript

Speaker: Tim Fischer, Great Solutions

Previous 1 2 … 9 10 11 12 13 14 15 16 17 … 75 76 Next

Upcoming Events

  • 08Feb

    Process and Design Validation for Devicemakers: A Deep Dive into Best Practices, Recent Trends and Regulatory Definitions

  • 09Feb

    The Inextricable Link Between Data Integrity and Quality Culture

  • 15Feb

    Advanced Compliance Writing CAPA: Mastering Failure Investigation and Root Cause Analysis

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 22Feb

    Best Practices for Developing and Maintaining a GxP Training Matrix

  • 07Mar

    FDA’s Remote Assessments v. Remote Interactive Evaluations: Do You Really Know the Difference?

Featured Products

  • FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485

    FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485

  • Selecting and Implementing Electronic Document Management Systems in the EU

    Selecting and Implementing Electronic Document Management Systems in the EU

Featured Stories

  • Consortium Gets EU Funding to Develop Continuous Blood Pressure Monitoring Device

  • FDA Approves GSK’s Oral Drug for Chronic Kidney Disease-Related Anemia

  • Aspivix’s Carevix Cleared to Reduce Pain, Bleeding in Gynecological Procedures

  • FDA Warns That Energy Supplement Contains Active Cialis Ingredient

The Revised ICH E8: A Guide to New Clinical Trial Requirements

Learn More
  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell or Share My Data
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Toll free 888.838.5578

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing